AKR1B10 accelerates glycolysis through binding HK2 to promote the malignant progression of oral squamous cell carcinoma
Abstract Background Oral squamous cell carcinoma (OSCC) remains a rampant oral cavity neoplasm with high degree of aggressiveness. Aldo–keto reductase 1B10 (AKR1B10) that is an oxidoreductase dependent on nicotinamide adenine dinucleotide phosphate (NADPH) has been introduced to possess prognostic p...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer
2024-04-01
|
| Serie: | Discover Oncology |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1007/s12672-024-00996-0 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|